Responder analyses for anti-amyloid immunotherapies for Alzheimer's disease. A paradigm shift by regulatory authorities is urgently needed / Salemme, Simone; Ancidoni, Antonio; Vanacore, Nicola. - In: BRAIN COMMUNICATIONS. - ISSN 2632-1297. - 5:5(2023), pp. 1-2. [10.1093/braincomms/fcad276]
Responder analyses for anti-amyloid immunotherapies for Alzheimer's disease. A paradigm shift by regulatory authorities is urgently needed
Salemme, SimonePrimo
Writing – Original Draft Preparation
;Ancidoni, AntonioSecondo
Writing – Original Draft Preparation
;Vanacore, Nicola
Ultimo
Writing – Original Draft Preparation
2023
File allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
Salemme_Responder-analyses_2023.pdf
accesso aperto
Note: Responder analyses for anti-amyloid immunotherapies for Alzheimer’s disease: a paradigm shift by regulatory authorities is urgently needed
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
316.66 kB
Formato
Adobe PDF
|
316.66 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
